Home
Issues
Browse By Topic
Conference Correspondent
- ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
- ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Association for Value-Based Cancer Care
Value-Based Care in Myeloma

William King

Authored Articles

Perioperative Nivolumab Extends Event-Free Survival in Resectable NSCLC

ESMO, Lung Cancer

December 2023, Vol 14, No 6

Phase 3 Trials Show Superiority of Targeted Treatments Over Chemotherapy in Oncogene-Addicted NSCLC

Lung Cancer, ESMO 2023 Highlights

December 2023, Vol 14, No 6

Future-Proofing Cancer Care Against Pandemics

December 2021, Vol 12, No 6

Reducing Racial Disparities in Cancer Care

December 2021, Vol 12, No 6

The Current and Future State of Medically Integrated Pharmacy in Oncology

December 2021, Vol 12, No 6

Top Trending Articles

1.

FDA Approves Acalabrutinib and Venetoclax Combination for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

2.

FDA Launches Unified Adverse Event Monitoring System to Enhance Transparency and Efficiency

3.

Financial Toxicity in Cancer Care: Why the Conversation Must Start Before Treatment Begins

Jan Hailey, MHL, CMC, CMCO, CMIS, CMOM, CMCA-E/M

Home
Issues
Browse By Topic
Conference Correspondent
- ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
- ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Association for Value-Based Cancer Care
Value-Based Care in Myeloma

Stay In The Know

Stay up to date on the matters of value in cancer by signing up for the free, bi-monthly VBCC print publication and VBCC weekly e‑newsletter.

About
About VBCC
Mission Statement
Advertising
Contact

Contribute
Submit a Manuscript
Editorial / Publishing Policies
Author Guidelines

Publications
Value-Based Cancer Care
Value-Based Care in Myeloma
Cholangiocarcinoma News

Amplity

© Amplity, Inc. All Rights Reserved. Privacy Policy.